Monday, February 17, 2014 11:48:37 AM
From the Ihub TOS:
1. You are completely responsible for your own investment decisions and who and what you believe on the boards. The boards are designed to help you gain the information edge you need to help you make your own decisions. You are responsible for properly analyzing and verifying any information you choose to rely upon.
Hugo's posts had no affect on my ability to invest and profit from INO stock. I would hope this would be the case for you also.
2. Messages posted by individuals may be misleading, deceptive, or in error. If you disagree with a posting, feel free to voice your opinion. It is the policy of iHub to allow our members to freely discuss issues in a free and open manner, and we will not take sides in disagreements or disputes based on investment sentiment or other subjective criteria.
3. You understand and agree that the Content and Services available on this Site are provided "AS IS" and that we assume no responsibility for the accuracy, relevance, timeliness, deletion, misdelivery or failure to store any Content, posts, images, communications or personalized settings.
4. Moderators of stock-specific boards are allowed to immediately remove any post that falls into the following categories: Threat, Off-Topic, Vulgarity, Privacy Violation, Spam, Personal Attack, or Duplicate.
Moderators neither ban posters or get to decide on requests to be unbanned. Currently I see that you are not listed in the posters that are currently banned.
I guess I will finish by saying, yes all opinions are welcome, as are your rebuttals to "misleading or untrue" posts, as long as they abide by the TOS.
1. You are completely responsible for your own investment decisions and who and what you believe on the boards. The boards are designed to help you gain the information edge you need to help you make your own decisions. You are responsible for properly analyzing and verifying any information you choose to rely upon.
Hugo's posts had no affect on my ability to invest and profit from INO stock. I would hope this would be the case for you also.
2. Messages posted by individuals may be misleading, deceptive, or in error. If you disagree with a posting, feel free to voice your opinion. It is the policy of iHub to allow our members to freely discuss issues in a free and open manner, and we will not take sides in disagreements or disputes based on investment sentiment or other subjective criteria.
3. You understand and agree that the Content and Services available on this Site are provided "AS IS" and that we assume no responsibility for the accuracy, relevance, timeliness, deletion, misdelivery or failure to store any Content, posts, images, communications or personalized settings.
4. Moderators of stock-specific boards are allowed to immediately remove any post that falls into the following categories: Threat, Off-Topic, Vulgarity, Privacy Violation, Spam, Personal Attack, or Duplicate.
Moderators neither ban posters or get to decide on requests to be unbanned. Currently I see that you are not listed in the posters that are currently banned.
I guess I will finish by saying, yes all opinions are welcome, as are your rebuttals to "misleading or untrue" posts, as long as they abide by the TOS.
Recent INO News
- Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China • PR Newswire (US) • 05/21/2026 08:05:00 PM
- INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights • PR Newswire (US) • 05/13/2026 08:05:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 05/08/2026 12:05:00 PM
- INOVIO to Report First Quarter Financial Results on May 13, 2026 • PR Newswire (US) • 05/01/2026 08:05:00 PM
- INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 04/06/2026 07:46:00 AM
- INOVIO Announces Pricing of $17.5 Million Public Offering • PR Newswire (US) • 04/02/2026 12:55:00 PM
- INOVIO Announces Proposed Public Offering • PR Newswire (US) • 04/02/2026 12:05:00 AM
- INOVIO to Participate in Upcoming Scientific Conference • PR Newswire (US) • 04/01/2026 02:29:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 03/30/2026 07:47:00 AM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/12/2026 08:05:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/10/2026 01:00:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 03/09/2026 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:55:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:54:42 PM
- INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • PR Newswire (US) • 03/05/2026 09:05:00 PM
- INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) • PR Newswire (US) • 03/04/2026 01:05:00 PM
- Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:13 PM
